Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penthrox versus nitrous oxide for painful emergency department procedures
ACTRN12624001117505Phase 3Not yet recruiting
- Sponsor
- Eastern Health
- Start
- Sep 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute pain comparing Penthrox with Nitrous oxide (2 arms). Primary endpoint: Patient-reported average pain intensity during the procedure. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
methoxyfluranenitrous oxide
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12624001117505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001117505.